Another Mass Retraction

Springer is pulling 64 papers from 10 of its journals because of “fabricated peer-review reports.”

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, PUBLICDOMAINPICTURESFollowing up on the hunch of an editor who noticed irregularities in the reviewers suggested by submitting authors, Springer has identified more than five dozen papers that were published through manipulated peer review. The publisher is now pulling 64 papers, which were published in 10 of its journals, it announced today (August 17).

“The peer-review process is one of the cornerstones of quality, integrity, and reproducibility in research, and we take our responsibilities as its guardians seriously,” the publisher’s statement reads. “We are now reviewing our editorial processes across Springer to guard against this kind of manipulation of the peer review process in future.”

Specifically, “we are working to support our external editors to make them aware of the issues and ensure that thorough checks of peer reviewers are completed,” Springer’s William Curtis, executive vice president for medicine and biomedicine, elaborated in an email to The Scientist. “Credentials from peer reviewers will be increasingly checked by our editorial office, which support our editors-in-chief, and some journals may request more information in the form of an institutional email address ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo